EICHORCondition: Chronic Limb-Threatening Ischemia · Sponsor: Aveera Medical, Inc.
The purpose of this study is to establish the safety and effectiveness of the Boomerang Catheter for percutaneous Deep Venous Arterialization (pDVA) to treat no-option Chronic Limb-Threatening Ischemia.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Arrowhead Regional Medical Center | San Bernardino, California, United States | — |
| Olive View-UCLA Medical Center | Sylmar, California, United States | — |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Torrance, California, United States | — |
| PIH Whittier Hospital | Whittier, California, United States | — |
| EndoVascular Consultants | Wilmington, Delaware, United States | — |
| First Coast Cardiovascular Institute | Jacksonville, Florida, United States | — |
| Rush University Medical Center | Chicago, Illinois, United States | — |
| Cardiovascular Institute of the South | Houma, Louisiana, United States | — |
| Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| Dartmouth Hitchcock Medical Center | Lebanon, New Hampshire, United States | — |
| Vascular Institute at AMI | Galloway, New Jersey, United States | — |
| American Endovascular and Amputation Prevention | West Orange, New Jersey, United States | — |
+ 13 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06311773